Idiopathic Inflammatory Myopathies (IIMs) trials recruiting in North Carolina

Fewer than 3 recruiting trials found.

All Idiopathic Inflammatory Myopathies (IIMs) trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
  NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte, Statesville